NDC 79739-7192 – Butalbital, Aspirin, and Caffeine

Butalbital 50 mg/1; Aspirin 500 mg/1; Caffeine 40 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CIII

Product NDC79739-7192

Product details

Brand name
Butalbital, Aspirin, and Caffeine
Generic name
Butalbital, Aspirin, and Caffeine
Labeler
LGM PHARMA SOLUTIONS, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA205230
Marketed since
October 18, 2021
Listing expires
December 31, 2026
Pharmacologic class
Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Butalbital, Aspirin, And Caffeine →

Package NDC codes (2)

Package NDCDescriptionSince
79739-7192-1100 CAPSULE in 1 BOTTLE (79739-7192-1)Oct 18, 2021
79739-7192-5500 CAPSULE in 1 BOTTLE (79739-7192-5)Oct 18, 2021

Other Butalbital, Aspirin, And Caffeine products